Several cross-sectional studies showed that insulin resistance and type 2 diabetes are associated with higher levels of C-reactive protein (CRP), interleukin-6 (IL-6), interleukin-1β, and tumor necrosis factor-α (TNF-α), which are markers of subclinical systemic inflammation [35]. This evidence concerns the gene IL6 and Insulin resistance.